Stryker Change in Accounts Payable 2010-2025 | SYK
Stryker annual/quarterly change in accounts payable history and growth rate from 2010 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
- Stryker change in accounts payable for the quarter ending June 30, 2025 was $-0.269B, a 31.22% increase year-over-year.
- Stryker change in accounts payable for the twelve months ending June 30, 2025 was $-0.589B, a 17.1% increase year-over-year.
- Stryker annual change in accounts payable for 2024 was $0.192B, a 149.35% increase from 2023.
- Stryker annual change in accounts payable for 2023 was $0.077B, a 73.45% decline from 2022.
- Stryker annual change in accounts payable for 2022 was $0.29B, a 11.85% decline from 2021.
| Stryker Annual Change in Accounts Payable (Millions of US $) |
|
|---|---|
| 2024 | $192 |
| 2023 | $77 |
| 2022 | $290 |
| 2021 | $329 |
| 2020 | $100 |
| 2019 | $63 |
| 2018 | $116 |
| 2017 | $21 |
| 2016 | $-16 |
| 2015 | $35 |
| 2014 | $13 |
| 2013 | $1 |
| 2012 | $-48 |
| 2011 | $44 |
| 2010 | $96 |
| 2009 | $-80 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $150.713B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.767B | 27.06 |
| Boston Scientific (BSX) | United States | $157.318B | 37.52 |
| EssilorLuxottica (ESLOY) | France | $147.808B | 0.00 |
| Medtronic (MDT) | Ireland | $118.836B | 16.76 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.610B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.076B | 25.18 |
| ResMed (RMD) | United States | $43.006B | 30.76 |
| Agilent Technologies (A) | United States | $34.551B | 22.52 |
| GE HealthCare Technologies (GEHC) | United States | $34.343B | 16.14 |
| Terumo (TRUMY) | Japan | $27.701B | 32.82 |
| Koninklijke Philips (PHG) | Netherlands | $27.289B | 18.05 |
| Insulet (PODD) | United States | $23.284B | 78.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.337B | 13.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.420B | 0.00 |
| Baxter (BAX) | United States | $12.604B | 9.74 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.222B | 30.20 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.958B | 10.70 |
| Envista Holdings (NVST) | United States | $3.609B | 25.26 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.369B | 8.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.283B | 14.57 |
| ICU Medical (ICUI) | United States | $3.164B | 21.54 |
| Haemonetics (HAE) | United States | $2.716B | 12.12 |
| LeMaitre Vascular (LMAT) | United States | $2.271B | 48.70 |
| Acuren (TIC) | United States | $2.108B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.894B | 11.92 |
| Curaleaf Holdings (CURLF) | Canada | $1.891B | 0.00 |
| AtriCure (ATRC) | United States | $1.872B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.757B | 75.45 |
| Phibro Animal Health (PAHC) | United States | $1.316B | 16.82 |
| AdaptHealth (AHCO) | United States | $1.300B | 18.48 |
| Tilray Brands (TLRY) | Canada | $1.266B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.241B | 2591.00 |
| Neogen (NEOG) | United States | $1.225B | 19.45 |
| Valneva SE (VALN) | France | $0.990B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.954B | 0.00 |
| InMode (INMD) | Israel | $0.936B | 8.66 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.624B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.607B | 0.00 |
| SNDL (SNDL) | Canada | $0.591B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.561B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.532B | 0.00 |
| Evolus (EOLS) | United States | $0.497B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.482B | 16.60 |
| CeriBell (CBLL) | United States | $0.442B | 0.00 |
| Owens & Minor (OMI) | United States | $0.390B | 3.46 |
| Sanuwave Health (SNWV) | United States | $0.386B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.306B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.302B | 0.00 |
| Omeros (OMER) | United States | $0.299B | 0.00 |
| High Tide (HITI) | Canada | $0.290B | 0.00 |
| Brainsway (BWAY) | Israel | $0.287B | 58.46 |
| Viemed Healthcare (VMD) | United States | $0.284B | 21.50 |
| Aurora Cannabis (ACB) | Canada | $0.282B | 0.00 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.241B | 0.00 |
| Quanterix (QTRX) | United States | $0.224B | 0.00 |
| Exagen (XGN) | United States | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.214B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.195B | 16.30 |
| TriSalus Life Sciences (TLSI) | United States | $0.191B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.160B | 19.65 |
| Biote (BTMD) | United States | $0.159B | 5.28 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.113B | 0.00 |
| MacroGenics (MGNX) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.19 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Safety Shot (SHOT) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.07 |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.83 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.95 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |